CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and in Vivo Characterization
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-1052
Full Text
Open PDFAbstract
Available in full text
Date
April 8, 2015
Authors
Publisher
American Association for Cancer Research (AACR)